藿朴夏苓汤联合西药对肥胖2型糖尿病患者脂代谢、胰岛功能及内脏脂肪的影响
CSTR:
作者:
作者单位:

绍兴市上虞区中医医院

作者简介:

通讯作者:

中图分类号:

基金项目:


The effect of Huopo Xialing Decoction combined with western medicine on lipid metabolism, pancreatic islet function and visceral fat in patients with obese type 2 diabetes mellitus
Author:
Affiliation:

Shaoxing Shangyu Hospital of Traditional Chinese Medicine

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨藿朴夏苓汤联合西药对肥胖2型糖尿病(type 2 diabetes mellitus,T2DM)患者脂代谢、胰岛功能及内脏脂肪的影响。方法 选取2025年1月至2026年1月于绍兴市上虞区中医医院治疗的300例肥胖T2DM患者,按随机数字表法分为观察组与对照组,每组各150例。对照组予二甲双胍联合达格列净口服,观察组加用经高效液相色谱(high performance liquid chromatography,HPLC)指纹图谱质控的藿朴夏苓汤,疗程12周。比较两组脂代谢指标[总胆固醇(total cholesterol,TC)、甘油三酯(triacylglycerol,TG)、低密度脂蛋白胆固醇(low density lipoprotein-cholesterol,LDL-C)及高密度脂蛋白胆固醇(high density lipoprotein-cholesterol,HDL-C)]、胰岛功能[空腹血糖(fasting blood glucose,FBG),空腹胰岛素(fasting insulin,FINS),稳态模型胰岛素抵抗指数(homeostasis model assessment of insulin resistance index,HOMA-IR)及HOMA-β]、内脏脂肪面积(visceral fat area,VFA)及临床疗效。结果 治疗后,观察组TC、TG、LDL-C、FBG、FINS、HOMA-IR水平均低于对照组(均P<0.05),HDL-C、HOMA-β水平均高于对照组(均P<0.05);观察组VFA小于对照组(P<0.05)。观察组糖化血红蛋白(glycated hemoglobin A1c,HbA1c)<7.0% 达标率及HbA1c 降幅≥1.0% 比例均优于对照组(均P<0.01),且综合临床有效率高于对照组(P<0.01)。结论 藿朴夏苓汤联合西药可有效改善肥胖T2DM患者脂代谢紊乱,减轻胰岛素抵抗,减少内脏脂肪堆积,提高血糖达标率,综合疗效优于单纯西药治疗,且安全性良好。

    Abstract:

    Objective To investigate the effects of Huopo Xialing Decoction combined with western medicine on lipid metabolism, pancreatic islet function, and visceral fat in patients with obese type 2 diabetes mellitus (T2DM). Methods A total of 300 patients with obese T2DM treated in Shaoxing Shangyu District Hospital of Traditional Chinese Medicine from January 2025 to January 2026 were enrolled and divided into an observation group and a control group by random number table method, with 150 cases in each group. The control group received metformin combined with dapagliflozin orally, while the observation group was additionally administered Huopo Xialing Decoction with high performance liquid chromatography (HPLC) fingerprint-based quality control. The treatment course lasted 12 weeks. Lipid metabolism indicators[total cholesterol (TC), triacylglycerol (TG), low density lipoproteincholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C)], pancreatic islet function[fasting blood glucose (FBG), fasting insulin (FINS), homeostasis model assessment of insulin resistance index (HOMA-IR), HOMA-β], visceral fat area (VFA), and clinical efficacy were compared between the two groups. Results After treatment, the levels of TC, TG, LDL-C, FINS, and HOMA-IR in the observation group were all lower than those in the control group(all P<0.05), while the levels of HDL-C and HOMA-β were higher than those of the control group (all P<0.05). VFA in the observation group was smaller than that in the control group (P<0.05). The HbA1c< 7.0% attainment rate and the proportion of patients with HbA1c reduction≥1.0% in the observation group were superior to those in the control group (all P<0.01), and the comprehensive clinical effective rate was higher than that of the control group (P<0.01). Conclusion Huopo Xialing Decoction combined with western medicine can effectively ameliorate lipid metabolism disorders, alleviate insulin resistance, reduce visceral fat accumulation, and improve the glycemic control target rate in patients with obese T2DM, with superior comprehensive efficacy compared with western medicine alone and a favorable safety profile.

    参考文献
    相似文献
    引证文献
引用本文

陈燃.藿朴夏苓汤联合西药对肥胖2型糖尿病患者脂代谢、胰岛功能及内脏脂肪的影响[J].生物医学工程学进展,2026,(4):250-254

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-07-29
  • 最后修改日期:2026-08-05
  • 录用日期:2026-08-06
  • 在线发布日期: 2026-10-20
  • 出版日期:
文章二维码